November 2016 Cough, Cold, & Flu

Xtampza ER

November 21, 2016

Rx Product News Profile

The FDA has approved Xtampza ER extended-release capsules, CII, for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Can We Trust Drug Interaction Research?

November 20, 2016

Drug Interactions

Over the past several years, many publications in the medical literature and the lay press have lamented the large percentage of study results that cannot be replicated in subsequent studies.

How to Discuss Pharmacogenetics with Your Patients

November 16, 2016

Pharmacogenetics Focus

As the medical community works toward fully embracing precision medicine, pharmacogenetics is anticipated to be the foundation of this important movement in personalized medicine.